Glucolive PG 1mg/500mg/15mg Tablet ER
Marketer
Allysia Lifesciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glucolive PG 1mg/500mg/15mg Tablet ER
Glycemicontrol TR 1mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, enhances blood sugar regulation in adults with type 2 diabetes. It promotes efficient insulin use, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and duration for Glycemicontrol TR. Take it with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, skip the missed dose. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, inform your doctor of any kidney, liver, or heart conditions. Pregnant or nursing individuals should seek medical advice before initiating treatment. Kidney function will be assessed before treatment commences. Limit alcohol consumption to minimize potential side effects.
Primary Ingredients of Glucolive PG 1mg/500mg/15mg Tablet ER
No text provided to rephrase.
Uses of Glucolive PG 1mg/500mg/15mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Glucolive PG 1mg/500mg/15mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Glucolive PG 1mg/500mg/15mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Glucolive PG 1mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glucolive PG 1mg/500mg/15mg Tablet ER:
Follow your physician's instructions precisely regarding dosage and treatment length for Glucolive PG 1mg/500mg/15mg Extended-Release Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Glucolive PG 1mg/500mg/15mg Tablet ER works:
Glucolive PG 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further enhances the body's sensitivity to insulin.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glucolive PG 1mg/500mg/15mg Extended-Release tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Glucolive PG tablets (1mg/500mg/15mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glucolive PG 1mg/500mg/15mg tablets are likely unsafe for breastfeeding mothers. Preliminary evidence indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glucolive PG 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glucolive PG 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glucolive PG 1mg/500mg/15mg Tablet ER :
Should you forget a Glucolive PG 1mg/500mg/15mg Extended-Release Tablet, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Glucolive PG 1mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently